tirzepatide presentation SUMMIT: a 'Huge Win' for HFpEF Patients With Obesity Tirzepatide: 3-Year Weight Loss Study

Results: We included 669 patients: 395 underwent GA, 189 non-GA, and 85 EC

Analytical Eco-Scale for assessing the greenness of analytical procedures

extremely short half-life (~13 minutes)

Standard protocol: 1mg IGF-1 LR3 + 2mL bacteriostatic water = 500mcg/mL concentration, where each 0.1mL (10 units on an insulin syringe) delivers 50mcg

Orforglipron weight loss results make it an effective oral GLP-1 weight loss option with the most flexible dosing of any medication in this class

These patients underwent a neurological examination, assessment of the ABCD2 score, cerebral neuroimaging and treatment with mono- or dual-antiplatelet or anticoagulant therapy